Physician profile
Joseph E Flack
NPI 1629095294
$22,379.37
in general payments reported to CMS, 2019-2025
27 companies · $5,372 in 2025
The $5,372 reported for 2025 was more than what 83% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,078 · 2020: $1,553 · 2021: $1,795 · 2022: $3,175 · 2023: $1,821 · 2024: $1,584 · 2025: $5,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,404 · Travel and Lodging: $3,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,404.42 |
| Travel and Lodging | $3,373.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $6,678.47 | 2019-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Edwards Lifesciences Corporation | $6,568.25 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $1,779.77 | 2021-2025 | Corevalve Evolut R, Penditure, Avalus |
| Abbott Laboratories | $1,771.99 | 2019-2024 | Epic, 2nd Gen Centrimag Primary Console, Navitor |
| Livanova USA, INC. | $1,547.42 | 2019 | |
| Abiomed | $1,265.53 | 2019-2024 | Impella |
| Medtronic Vascular, INC. | $606.16 | 2019-2020 | |
| Biomerieux INC | $365.53 | 2019-2022 | |
| Stryker Corporation | $174.01 | 2021 | |
| Medistim USA, INC. | $173.88 | 2019 | |
| Atricure, INC. | $165.14 | 2019-2025 | Synergy Ablation System |
| Horizon Therapeutics Plc | $125.00 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2019 | |
| Baxter Healthcare | $124.59 | 2019 | |
| Medical Device Business Services, INC. | $123.80 | 2024 | Vistaseal |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $118.75 | 2019 | |
| Lsi Solutions INC | $109.24 | 2019 | |
| Corcym INC | $92.04 | 2022 | |
| Ethicon US, LLC | $90.56 | 2024 | Mega Soft, Surgicel Nu-Knit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.58 | 2022-2025 | Lifevest |
| Shockwave Medical, INC | $87.41 | 2022 | |
| Elutia, INC. | $71.98 | 2020 | |
| Alcresta Therapeutics, INC. | $36.69 | 2023 | Relizorb |
| Angiodynamics, INC. | $26.68 | 2022 | |
| Haemonetics Corporation | $23.86 | 2025 | Teg6s Hemostasis System |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $20.71 | 2025 | |
| Janssen Pharmaceuticals, INC | $19.33 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Flack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.